Health Economics of Managing Melanoma in 2018 | 12 min
Health Economics of Managing Melanoma in 2018 | Overview
Skin cancer is the most expensive cancer to the Australian Government. With the rising costs of healthcare and an increased prevalence of people living with melanoma, we need evidence-based care to justify what we do. A/Prof Rachael Morton discusses the health economic implications of managing melanoma.
A/Prof Rachael Morton
Health Economics Researcher, Melanoma Institute Australia | Director of Health Economics, NHMRC Clinical Trials Centre, The University of Sydney